Availability on request
PancragenPancragen (KEDW) is a short peptide targeting the pancreas, developed within the Khavinson system; it is specifically the tetrapeptide Lys-Glu-Asp-Trp (KEDW). Research on this peptide primarily focuses on islet function, insulin and blood glucose metabolism, and age-related decline in pancreatic function. Its key areas of action include islet and pancreatic cell function, blood glucose regulation, insulin metabolism, and age-related pancreatic function.
20 mg · 10 vials




